MedTrace Logo

Lumax 740 Master Study

NCT01454050 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 189

Last updated 2012-11-28

No results posted yet for this study

Summary

The objective of this study is to prove the safety and efficacy of the Lumax 740 ICD family. Primarily, the newly implemented RV/LV Capture Control algorithm is evaluated, which automatically measures the RV/LV threshold and subsequently adjusts the pacing output.

Conditions

  • Safety and Efficacy of the Lumax 740 ICD Family

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Principal Investigators

  • Gunnar Klein, Prof. Dr. · Herz im Zentrum Hannover, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01454050 on ClinicalTrials.gov